Welcome
The United States Law Week

Rite Aid Wins Delay of Generic Drug Price Case Pending Appeal

July 31, 2020, 3:06 PM

Rite Aid Corp. won’t have to litigate claims over alleged excessive charges for generic drugs while it appeals a decision denying its motion to force the plaintiffs to arbitrate the case, a federal court in California said.

The retail pharmacy raised serious legal questions over its right to arbitration and would be irreparably harmed if forced to go to trial before its appeal is completed, the U.S. District Court for the Southern District of California said Thursday.

The customers who alleged they wound up paying excessive copayments for the drugs due to Rite Aid’s actions will suffer some prejudice due...

To read the full article log in. To learn more about a subscription click here.